Equity
-€120,420
Debts exceed assets in financial year 2025.
CRYOSTORAGE
Lifetime
17 annual accounts with figures on one time axispeak €39,015 (2022)
-€453▼ €5
lowest -€37,058 (2017)
-€26,383▼ €8,288
peak €64,103 (2009)
-€120,420▼ €26,383
€519,278▲ 5.2%
Board2 names since 2015
1 director
Owners3 names in the annual accounts
Documentsfilings and deeds
29-01-20262 days before the deadline
2025micro format
Loss of €26,383Equity from -€94,037 to -€120,420
Key points
from the 2025 annual accountsLosses
-€65,532 in three years
Every financial year from 2023 to 2025 closed with a loss. 2025 was the heaviest.
Debts
€519,278 130% of the balance sheet
Filings
17 annual accounts since 2009
The 2016 accounts came 1 day late. The other nine of the last ten were filed on time.
At the same address
95 companies
Position in the sector
-30.2%
Lower solvency than 95% of companies in human health. Sector median 63.1% · 21,330 companies.
Turnover not published (abbreviated or micro format)
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,333 companies had the same profile as CRYOSTORAGE has now. Each dot stands for 6 companies, two years later.
90.5%
were still trading
5.9%
stopped another way
2.8%
went bankrupt
Another 0.8% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,333 companies, not a prediction for CRYOSTORAGE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Reappointment: (director)
Permanent representative: · Board meeting of 01-12-2022 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0899649957
Registered office moved from Sint-Denijs-Westrem to Ghent
New registered office: Esplanade Oscar Van De Voorde 1 te 9000 Gent · Previous registered office: Adelaarsstraat 24, 9051 Sint-Denijs-Westrem · Permanent representative: · Board meeting of 10-06-2016 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| CRYOSTORAGE Ghent | €0.4m | -€453 | -30.2% | - |
| AMAKEM Hasselt | €0.4m | -€8,122 | 100.0% | - |
| DANOS LABORATORY Ixelles | €0.3m | -€27,299 | 38.0% | - |
| ABBIO Watermael-Boitsfort | €0.4m | -€97,079 | -22.6% | - |
| DName-iT Leuven | €0.5m | -€71,430 | 21.5% | - |
| Expert Service & Advice in Healthcare Hoeilaart | €1.1m | -€857 | 98.2% | - |
| LABEUROP Ottignies-Louvain-la-Neuve | €0.6m | €2,107 | 52.1% | - |
These companies have the same main activity as CRYOSTORAGE: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €298,000 and €1.1m, founded between 1998 and 2014.
Official details
Source: KBO- Status
- Active since 05-08-2008Normal situation
- Registered office
- 96 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 14 November 2026.
- Activity
- Medical imaging and medical laboratoriesNACE 86910and 1 other
- Establishment unit
- 2.173.637.3669000 Ghent, since 15-10-2008
- Financial year end
- 30 June
- Peppol
- Reachable since 25-08-2025
Annual accounts to 30-06-2025
- €398,857▼ 0.1%
- Filing
- Filed on 29-01-2026, 2 days before the end of the filing period
Insights on CRYOSTORAGE
CRYOSTORAGE files the micro format. That format states no turnover. The gross margin rose from -€1,267 in 2009 to -€453 in 2025.
NEVIMO holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about CRYOSTORAGE
- What is the company number of CRYOSTORAGE?
- The company number of CRYOSTORAGE is 0899.649.957. The VAT number is the same number with BE in front: BE 0899.649.957.
- Where is CRYOSTORAGE based?
- The registered office is at Esplanade Oscar Van de Voorde 1, 9000 Ghent.Company details
- What does CRYOSTORAGE do?
- According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
- What is the legal form of CRYOSTORAGE?
- CRYOSTORAGE is a public limited company (NV).
- When was CRYOSTORAGE founded?
- CRYOSTORAGE was founded on 05-08-2008.
- Is CRYOSTORAGE still active?
- Yes, CRYOSTORAGE is an active enterprise in the KBO register.
- What is the turnover of CRYOSTORAGE?
- The annual accounts for financial year 2025 state no turnover. The abbreviated or micro format does not require it.Financials
- Is CRYOSTORAGE profitable?
- In financial year 2025, CRYOSTORAGE made a loss of €26,383.
- Where can I find the annual accounts of CRYOSTORAGE?
- CRYOSTORAGE filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of CRYOSTORAGE due?
- CRYOSTORAGE must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.